S1836Referred to Committee

SMART Prices Act

Share:
Introduced
In Committee
3
Passed One Chamber
4
Passed Both
5
Signed into Law
119th
Congress
2025-05-21
Introduced
26
Cosponsors
S
ⓘ
Type

Sponsor

Amy Klobuchar
Amy Klobuchar
Democrat · MN · Senator
Votes with party: 80.8% (848 recorded votes)

Full profile: /officials/K000367

Source: Congress.gov · FEC

Cosponsors (26)

Members who have signed on to support this bill since introduction. Source: Congress.gov.

26 cosponsors on record at Congress.gov. The named list is syncing into Govwatch and will appear here shortly — view on Congress.gov in the meantime.

Latest Action

The most recent step in the bill's legislative path. Committee Activity below shows referrals and reports; the full action-by-action history including floor proceedings lives at Congress.gov →

Read twice and referred to the Committee on Finance.

2025-05-21

Source: Congress.gov

Committee Activity

Currently in

Plain-English Summary

The legislation would require pharmaceutical companies to justify and potentially negotiate drug prices with Medicare, aiming to make prescription medications more affordable for seniors and other patients. It would give the federal government more authority to review whether drug prices are reasonable compared to their actual development costs and effectiveness. This could lower out-of-pocket costs for people taking expensive medications, though it might also affect how quickly new drugs reach the market.

AI-assisted summary generated from the official bill metadata (title, subjects, actions) sourced from Congress.gov. Cached and reviewed. Always verify against the official text linked below.

Subjects

Health
Full bill text is not yet cached locally.
Open text viewRead on Congress.gov

Related legislation

Bills by the same sponsor or covering overlapping subjects.